カテゴリ： 世界, 部品/材料, Market Monitor Global

動物医薬品用フルララネルAPIのグローバル市場展望 2023年-2029年：純度≧98%、純度＜98%

■ 英語タイトル：Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY2421）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY2421
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：化学＆材料
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[動物医薬品用フルララネルAPIのグローバル市場展望 2023年-2029年：純度≧98%、純度＜98%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の動物医薬品用フルララネルAPI市場規模と予測を収録しています。・世界の動物医薬品用フルララネルAPI市場：売上、2018年-2023年、2024年-2029年
・世界の動物医薬品用フルララネルAPI市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の動物医薬品用フルララネルAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度≧98%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

動物医薬品用フルララネルAPIのグローバル主要企業は、Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、動物医薬品用フルララネルAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の動物医薬品用フルララネルAPI市場：タイプ別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場：タイプ別市場シェア、2022年
・純度≧98%、純度＜98%

世界の動物医薬品用フルララネルAPI市場：用途別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場：用途別市場シェア、2022年
・内服薬、外用薬

世界の動物医薬品用フルララネルAPI市場：地域・国別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における動物医薬品用フルララネルAPIのグローバル売上、2018年-2023年
・主要企業における動物医薬品用フルララネルAPIのグローバル売上シェア、2022年
・主要企業における動物医薬品用フルララネルAPIのグローバル販売量、2018年-2023年
・主要企業における動物医薬品用フルララネルAPIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology

*************************************************************

・調査・分析レポートの概要
動物医薬品用フルララネルAPI市場の定義
市場セグメント
世界の動物医薬品用フルララネルAPI市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の動物医薬品用フルララネルAPI市場規模
世界の動物医薬品用フルララネルAPI市場規模：2022年 VS 2029年
世界の動物医薬品用フルララネルAPI市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの動物医薬品用フルララネルAPIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の動物医薬品用フルララネルAPI製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：純度≧98%、純度＜98%
動物医薬品用フルララネルAPIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：内服薬、外用薬
動物医薬品用フルララネルAPIの用途別グローバル売上・予測

・地域別市場分析
地域別動物医薬品用フルララネルAPI市場規模 2022年と2029年
地域別動物医薬品用フルララネルAPI売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology
...

This report aims to provide a comprehensive presentation of the global market for Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient. This report contains market size and forecasts of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in global, including the following market information:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient companies in 2022 (%)
The global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity ≥98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient include Nissan Chemical, HIKAL Ltd., HuBei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu Group, Zhejiang Gihi Chemicals, Hunan Huateng Pharmaceutical and Taizhou Crene Biotechnology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2022 (%)
Purity ≥98%
Purity <98% Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons) Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2022 (%) Oral Drug External Drug Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons) Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues share in global market, 2022 (%) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales in global market, 2018-2023 (Estimated), (Tons) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Nissan Chemical HIKAL Ltd. HuBei Masteam Bio-tech Jiangsu Rivocean Shaanxi Dideu Group Zhejiang Gihi Chemicals Hunan Huateng Pharmaceutical Taizhou Crene Biotechnology Outline of Major Chapters: Chapter 1: Introduces the definition of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, market overview. Chapter 2: Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market size in revenue and volume. Chapter 3: Detailed analysis of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Overall Market Size
2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size: 2022 VS 2029
2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales: 2018-2029
3 Company Landscape
3.1 Top Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue by Companies
3.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales by Companies
3.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size Markets, 2022 & 2029
4.1.2 Purity ≥98%
4.1.3 Purity <98% 4.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 4.2.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 4.2.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 4.2.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 4.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 4.3.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 4.3.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 4.3.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 4.4 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2022 & 2029 5.1.2 Oral Drug 5.1.3 External Drug 5.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 5.2.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 5.2.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 5.2.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 5.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 5.3.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 5.3.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 5.3.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 5.4 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029 6 Sights by Region 6.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2022 & 2029 6.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 6.2.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 6.2.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 6.2.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 6.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 6.3.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 6.3.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 6.3.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 6.4 North America 6.4.1 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.4.2 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.4.3 US Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.4.4 Canada Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.4.5 Mexico Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5 Europe 6.5.1 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.5.2 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.5.3 Germany Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.4 France Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.5 U.K. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.6 Italy Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.7 Russia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.8 Nordic Countries Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.9 Benelux Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6 Asia 6.6.1 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.6.2 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.6.3 China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.4 Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.5 South Korea Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.6 Southeast Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.7 India Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.7 South America 6.7.1 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.7.2 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.7.3 Brazil Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.7.4 Argentina Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.8.2 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.8.3 Turkey Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.4 Israel Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.5 Saudi Arabia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.6 UAE Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 7 Manufacturers & Brands Profiles 7.1 Nissan Chemical 7.1.1 Nissan Chemical Company Summary 7.1.2 Nissan Chemical Business Overview 7.1.3 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.1.4 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.1.5 Nissan Chemical Key News & Latest Developments 7.2 HIKAL Ltd. 7.2.1 HIKAL Ltd. Company Summary 7.2.2 HIKAL Ltd. Business Overview 7.2.3 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.2.4 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.2.5 HIKAL Ltd. Key News & Latest Developments 7.3 HuBei Masteam Bio-tech 7.3.1 HuBei Masteam Bio-tech Company Summary 7.3.2 HuBei Masteam Bio-tech Business Overview 7.3.3 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.3.4 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.3.5 HuBei Masteam Bio-tech Key News & Latest Developments 7.4 Jiangsu Rivocean 7.4.1 Jiangsu Rivocean Company Summary 7.4.2 Jiangsu Rivocean Business Overview 7.4.3 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.4.4 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.4.5 Jiangsu Rivocean Key News & Latest Developments 7.5 Shaanxi Dideu Group 7.5.1 Shaanxi Dideu Group Company Summary 7.5.2 Shaanxi Dideu Group Business Overview 7.5.3 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.5.4 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.5.5 Shaanxi Dideu Group Key News & Latest Developments 7.6 Zhejiang Gihi Chemicals 7.6.1 Zhejiang Gihi Chemicals Company Summary 7.6.2 Zhejiang Gihi Chemicals Business Overview 7.6.3 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.6.4 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.6.5 Zhejiang Gihi Chemicals Key News & Latest Developments 7.7 Hunan Huateng Pharmaceutical 7.7.1 Hunan Huateng Pharmaceutical Company Summary 7.7.2 Hunan Huateng Pharmaceutical Business Overview 7.7.3 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.7.4 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.7.5 Hunan Huateng Pharmaceutical Key News & Latest Developments 7.8 Taizhou Crene Biotechnology 7.8.1 Taizhou Crene Biotechnology Company Summary 7.8.2 Taizhou Crene Biotechnology Business Overview 7.8.3 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.8.4 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.8.5 Taizhou Crene Biotechnology Key News & Latest Developments 8 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, Analysis 8.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, 2018-2029 8.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity of Key Manufacturers in Global Market 8.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Supply Chain Analysis 10.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Value Chain 10.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Upstream Market 10.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 動物用医薬品のグローバル市場展望 2023年-2029年：経口、注射、その他
  • 医薬品用ドキュサートナトリウムのグローバル市場展望 2023年-2029年：純度≧99%、98%≦純度≦99%
  • 高繊維飼料成分のグローバル市場展望 2023年-2029年：小麦、トウモロコシ、その他
  • 動物用バシトラシン亜鉛プレミックスのグローバル市場展望 2023年-2029年：粉末、顆粒
  • 単一成分コデインのグローバル市場展望 2023年-2029年：普通錠、徐放錠
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY2421 )"動物医薬品用フルララネルAPIのグローバル市場展望 2023年-2029年：純度≧98%、純度＜98%" (英文：Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。